The active form of the Xenopus X-box binding protein 1 (xXBP1) partially synergizes and partially antagonizes with BMP-4 signaling. xXBP1 overexpression inhibits mesoderm differentiation and formation of neural tissues. A functional knockdown promotes differentiation of lateral and dorsal mesoderm but not of ventral mesoderm and of neuroectoderm. We show that the active form of xXBP1 in gastrula and early neurula stage embryos is generated by removal of exon 4 and not by an endoribonuclease activity in the endoplasmic reticulum. The N-terminal region of xXBP1 which contains the basic leucine-zipper also contains a nuclear localization signal and both, the N-terminal as well as the C-terminal regions are required for xXBP1 function. The effects of xXBP1 are in part correlated to a regulatory loop between xXBP1 and BMP-4. xXBP1 and BMP-4 stimulate mutually the transcription of each other, but xXBP1 inhibits the BMP-4 target gene, Xvent-2. Both, in vitro and in vivo assays demonstrate that xXBP1 interacts with BMP-4 and Xvent-2B promoters. GST-pulldown assays reveal that xXBP1 can interact with c-Jun, the transcriptional co-activator p300 and with the BMP-4 responsive Smad1. On the other hand, xXBP1 also binds to the inhibitory Smads, Smad6 and Smad7, that can act as transcriptional co-repressors. Based on these data, we conclude that xXBP1 might function as an inhibitor of mesodermal and neural tissue formation by acting either as transcriptional activator or as repressor. This dual activity depends upon binding of cofactors being involved in the formation of distinct transcription complexes. q
Introduction
During Xenopus embryogenesis, TGF-b signaling is an important player in germ layer induction and pattern formation (De Robertis et al., 2000) . Distinct TGF-b family members, the Nodal related proteins, act to induce both endoderm and mesoderm and are also involved in neural patterning (Schier, 2003) . Bone morphogenetic proteins (BMPs), other members of the TGF-b family, specify dorsal/ventral patterning (De Robertis and Kuroda, 2004) . When BMP-4 or its direct target gene Xvent-2 is misexpressed at the dorsal side of Xenopus embryos, dorsal mesoderm is converted into ventral mesoderm by inhibiting dorsalizing genes such as chordin or goosecoid (Jones et al., 1996; Henningfeld et al., 2000; Onichtchouk et al., 1998) . The molecular mechanism of signal transduction by BMPs, or more broadly, by TGF-b has been well characterized (Whitman, 1998; von Bubnoff and Cho, 2001; Shi and Massague, 2003) . Upon binding to the BMP ligand, a type II receptor phosphorylates a type I receptor, which subsequently activates by phosphorylation receptor-specific BMP-responsive Smads, like Smad1 or Smad5. These phosphorylated Smads associate with the co-Smad, Smad4, and translocate into nuclei, where they cooperate with other transcription factors to regulate BMP target genes. TGF-b responsive Smads are Smad2 and Smad3, which form a regulatory complex with Smad4 to regulate TGF-b target genes. BMP-4 signaling is on the other hand negatively regulated by the inhibitory Smads (I-Smads), Smad6 and Smad7 (Imamura et al., 1997; Hata et al, 1998; Nakayama et al., 1998a,b; Nakao et al., 1997; Hayashi et al., 1997) . Xvent-2 and the pseudo-allelic gene Xvent-2B have been shown to be direct target genes of BMP-4 signaling (Hata et al., 2000; Henningfeld et al., 2000) . Noteworthy, the autoregulory loop of BMP-4 expression is mediated by Xvent-2, because this factor activates BMP-4 transcription by binding to an enhancer element in the second intron . However, the BMP-4 autoregulatory loop contains additional transcription factors, like c-Jun . The promoters of Xvent-2 and Xvent-2B genes contain a BMPresponsive element with binding sites for Smads and distinct transcription factors, like OAZ and Xvent-2 itself, that serve to enhance the binding between Smads and DNA (Hata et al., 2000; Henningfeld et al., 2000 Henningfeld et al., , 2002 . We could recently show that Oct-25 as an additional factor is included in the Xvent-2B gene regulatory complex (Cao et al., 2004) . This type of regulation of Xvent-2B may account for an inhibition or a delay of terminal differentiation during early embryogenesis.
xXBP1 was identified as the Xenopus homologue to the X-box binding protein 1 (XBP1) (Zhao et al., 2003) . It had been shown to be essential for liver development and terminal differentiation of plasma cells in mouse (Reimold et al., 2000 (Reimold et al., , 2001 . At the molecular level, XBP1 is a crucial player in the unfolded protein response (UPR) by regulating synthesis of chaperones required in the endoplasmic reticulum (Lee et al., 2003) . XBP1 overexpression also leads to elevated levels of membrane phopspholipids and increases the volume of the endoplasmic reticulum (Sriburi et al., 2004) . In Xenopus embryogenesis, overexpressed xXBP1 results in a phenotypic effect similar to that observed by the activation of BMP-4 signaling (Zhao et al., 2003) . However, our present examination of the xXBP1 gain-of-function phenotype revealed that not only dorsal but also ventral mesoderm formation is inhibited, an effect which is clearly different from the action of BMP-4 or its target genes. Loss-of-function assays demonstrated that xXBP1 is involved in suppression of mesodermal and neural development. xXBP1 and BMP-4 can mutually activate the transcription of each other, however, the BMP-4 target gene Xvent-2 is inhibited. Furthermore, we found that xXBP1 binds Smad4, BMP-4 responsive Smad1, TGF-b responsive Smad3, the I-Smads, c-Jun, and the transcriptional coactivator p300. All these bindings occur at the C-terminal region of xXBP1, except for I-Smads, which also bind to the N-terminal region. Considering the role of I-Smads as corepressors, we propose that xXBP1 can also function as transcriptional repressor. By in vitro and in vivo analyses we demonstrate that xXBP1 interacts with the promoters of BMP-4 and Xvent-2B genes. We conclude that xXBP1 is a regulatory component for BMP-4 gene activation and Xvent-2B gene repression. Such regulatory circuits may be required for the correct spatial patterning during Xenopus embryogenesis.
Results

Active xXBP1 can be generated by an alternative splice process
Like in other vertebrates, the Xenopus XBP1 gene (xXBP1) is composed of five exons giving rise to a mature transcript encoding a protein containing 254 amino acids. In response to endoplasmic reticulum (ER) stress, an ER transmembrane kinase/endoribonuclease, called IRE1, oligomerizes, is activated by autophosphorylation and excises by its endoribonuclease activity 26 nucleotides of XBP1 RNA (Yoshida et al., 2001; Lee et al., 2002) . The resulting spliced form of XBP1 RNA produces by shift of the open reading frame a C-terminal transactivation domain as part of a highly active transcription factor (Yoshida et al., 2001 ) which, in Xenopus, comprises 396 amino acids (Fig. 1A) . Both the unspliced and the spliced versions of xXBP1 RNA were found to be present in the Xenopus EST databases from embryonic cDNA libraries (unspliced: Genbank accesssion nos. CA791954 and BP672264; spliced: Genbank accession no. BC043852). However, an active xXBP1 version is also generated by a conventional nuclear splice process, in which exon 4 is completely eliminated as an intron. Since the open reading frame of exon 5 is shifted in the same way as by the IRE1 complex, the resulting proteins share the entire C-terminal region including the transactivation domain. This alternatively spliced form of xXBP1 had previously been found in a Xenopus cDNA library prepared from animal caps treated with activin A Fig. 1 . Splice variants of xXBP1 during embryogenesis. (A) The primary transcript is spliced to yield mature RNA containing five exons. Endoplasmic reticulum stress leads by endoribonuclease activity of IRE1 to removal of 26 nucleotides from exon 4, resulting in a frame shift and production of a highly active transcription factor (Yoshida et al., 2001) . This frame shift is also generated by complete removal of exon 4 as observed in the previously identified cDNA clone isolated from an activin A induced animal cap cDNA library (Zhao et al., 2003) . (B) The presence of these splice variants in RNA of different developmental stages (Nieuwkoop and Faber, 1967) was analyzed by RT-PCR using primers derived from exons 3 (5 0 -AAGAAGAAGAAGAA-GAATCACAG-3 0 ) and 5 (5 0 -CATAGGCAAGCAACAAGTCTG-3 0 ), respectively. The reaction gives rise to three bands corresponding to 245 (unspliced), 219 (26 nucleotides removed) and 81 nucleotides (lacking exon 4). Note, that the RNA lacking exon 4 is only generated during gastrula and early neurula stages. Lane M contains a 50/100 bp size marker (GeneRuler Tm Fermentas). RT-PCR for ODC (ornithin decarboxylase) is used as loading control for the amount of RNA.
(Genbank accession no. AF358133) and gives rise to a 350 amino acid protein (Zhao et al., 2003) . To analyze the relative distribution of these splice variants during embryogenesis, we performed RT-PCR by using RNA of different developmental stages and analyzed the products on an acrylamide gel (Fig. 1B) . The major band (245 bp) during all stages of development represents the unspliced variant (encoding 254 aa), whereas a faster migrating band (219 bp) encoding the active transcription factor (396 aa) constituted only a minor fraction on PCR product level. Maternal transcripts encoding this active version vanished until the gastrula stage, but the band re-appeared at stage 15. Transcripts of the version lacking exon 4 (encoding 350 aa) were not detected before the gastrula stage, but then the corresponding band (81 bp) replaced the other active version lacking the 26 nucleotides. Although the 81 bp band on the gel is less intense than that of the unspliced version, a quantitative densitometric analysis using a 2100 Bioanalyzer (Agilent Technologies) demonstrated, that the number of molecules of the version lacking exon 4 is nearly identical to that of the unspliced version (data not shown). At the end of neurulation, this RNA gradually disappeared. In summary, during gastrula and early neurula stages of development the active form of xXBP1 is exclusively contributed by complete removal of exon 4 and not by deletion of 26 nucleotides. However, both versions exhibit the same biological activity. Microinjection of the IRE1 spliced active xXBP1 RNA into Xenopus embryos led to indistinguishable results from those obtained by overexpression of the version lacking exon 4 with respect to phenotypic alterations and expression behaviour of some selected marker genes for ectoderm, mesoderm and endoderm (see Supplementary Fig.  S1B,D) . In contrast, injection of the unspliced version, even at high amounts, did not result in any phenotypic alterations of injected embryos (see Supplementary Fig. S1C ). This observation corresponds to previous findings that the unspliced version does not only lack the transactivation domain but also has no transactivation ability (Yoshida et al., 2001) . This is surprising, because the unspliced version of the protein theoretically could interfere with the active versions by heterodimerization. However, the unspliced protein does not exist in vivo. Whether this also holds true for Xenopus and whether this is due to a lack of translation, like in yeast, or to rapid degradation of the protein, like in mouse, remains to be elucidated.
2.2. Functional knockdown of xXBP1 promotes early mesoderm formation and dorsal and paraxial mesoderm differentiation at later stages Overexpression of xXBP1 in Xenopus embryos resulted in a seemingly ventralized phenotype morphologically similar to that caused by activating BMP-4 signaling (Zhao et al., 2003) . We therefore expected that inhibition of xXBP1 function in vivo would dorsalize Xenopus embryos, as in the case of inhibition of BMP-4 signaling (Suzuki et al, 1994; Onichtchouk et al., 1998) . We applied an antisense morpholino oligo to knock down the function of xXBP1. This approach affects all variants of xXBP1 RNA, regardless whether they are spliced or not. Before injection, we examined if the morpholino oligo against xXBP1 mRNA (MOxXBP) can efficiently inhibit translation. An in vitro transcription/translation assay demonstrated this to be the case. In this assay, protein translation was effective when the pBK-CMV-xXBP1 plasmid, which contains the MOxXBP binding sequence, was added alone or added together with a standard control morpholino (ctrlMO) (Fig. 2A,  lanes 2 and 4) . However, when the plasmid was added together with MOxXBP, xXBP1 protein was not detected any more ( Fig. 2A, lane 3) .
Different doses of MOxXBP and ctrlMO were injected into all four blastomeres of 4-cell stage Xenopus embryos. We observed no significant phenotypic changes when MOxXBP was injected at 10 or 20 ng per embryo (data not shown). When the injected dose was increased to 50 ng, significant shortening of anterio-posterior body axis and bending of dorso-ventral body axis occurred in the embryos at stage 32 (37/43 embryos affected. Fig. 2B ), whereas the embryos injected with 50 ng of ctrlMO remained normal (Fig. 2C) . The observed phenotype could be rescued by coinjection with 200 pg of xXBP1 mRNA (21/29 embryos rescued. Fig. 2D ), confirming that the functional knockdown of xXBP1 is specific. We next investigated whether this phenotype can also be rescued by components of BMP-4 signaling. Indeed, coinjection of 50 ng of MOxXBP together with 50 pg of BMP-4 RNA led in 35 out of 49 embryos to an apparent rescue (Fig. 2E, F) . These results are in agreement with the previously noted role of xXBP1 as a regulatory component of BMP-4 signaling (Zhao et al., 2003) . Interestingly, the knockdown phenotype was also rescued by co-injection of 40 pg of ADMP transcript (119/162 embryos rescued. Fig. 2G, H) . ADMP is a ventralizing gene that is expressed in dorsal mesoderm (Moos et al., 1995) . This colocalization with xXBP1 and the rescue suggest that a regulatory relationship exists between ADMP and xXBP1.
As we did not observe any obvious dorsalization in the knockdown phenotype, like for example a secondary axis, we further investigated the phenotype by analyzing the expression of genes involved in mesodermal patterning or differentiation. RT-PCR from MOxXBP injected embryos at stage 11 demonstrated an upregulation of the pan-mesodermal marker gene Xbra, the dorsal marker genes chordin and goosecoid as well as the ventral marker gene Xvent-2, while BMP-4 expression and that of the BMP-4 downstream target Xmsx2 was not significantly altered ( Fig. 2I) . Therefore, also the results from these experiments cannot account for the expected total dorsalization of embryos, because ventral genes including Xvent-2 and BMP-4 are not repressed. Instead, these findings implicate that loss of xXBP1 function does not simply dorsalize ventral mesoderm but promotes both ventral and dorsal mesoderm formation. At developmental stages 18 and 30, transcription of the axial and paraxial mesodermal genes Xnot and XMyoD is upregulated. However, transcription of the a-globin gene, which is expressed in the ventralmost mesoderm, is strongly downregulated (Fig. 2I ). While the neural marker NCAM is inhibited, expression of the epidermal keratin gene and the endodermal genes XHex and endodermin (Edd) are not significantly affected. We conclude that the functional knockdown of xXBP1 does not dorsalize the embryos but promotes ventral and dorsal mesoderm formation during gastrulation. At later stages, axial and paraxial mesodermal markers are enhanced, while ventral differentiation markers, like a-globin, and neural markers, like NCAM, are suppressed.
xXBP1 inhibits mesodermal and neural differentiation
As the xXBP1 functional knockdown did not result in a dorsalized phenotype, we next asked whether the embryos are actually ventralized by overexpression of xXBP1 RNA as reported previously (Zhao et al., 2003) . We analyzed by RT-PCR the expression of a set of genes that mark dorsal-ventral patterning at an early stage and tissue differentiation at later stages. Embryos were injected with 600 pg of xXBP1 RNA into all four blastomeres at 4-cell stage and collected at stage 11.5, 18 and 30, respectively. RT-PCR revealed that, in contrast to the functional knockdown as described above, transcription of the dorsal mesodermal marker genes chordin and goosecoid was significantly inhibited during gastrulation (Fig. 3A) . Simultaneously, the pan-mesodermal marker Xbra and the ventralizing gene Xvent-2 were also repressed. The results suggest that overexpression of xXBP1 does not only suppress dorsal but also ventral mesoderm formation. In line with this notion, XMyoD, a-actin and a-globin were found to be repressed at later stages. While the endodermal markers XHex and Edd were not changed, the neural marker NCAM was inhibited to a similar extent as within the functional knockdown. Taken together, the results of loss-and gain-of-function analyses, it is concluded that xXBP1 mainly interferes with mesoderm formation and differentiation of neural tissues, while endodermal gene expression is not or less affected.
2.4. Regulatory relationships between xXBP1, BMP-4, Xvent-2, and ADMP Because xXBP1 gain-of-function results in a phenotype that is not fully ventralized and the loss-of-function phenotype can be rescued by BMP-4, we were interested in how the regulatory relationship is between xXBP1 and BMP-4 signaling. 400 pg of xXBP1 or BMP-4 RNA were injected dorsally into 4-cell stage embryos. Embryos were collected at stage 10.5 and subject to whole mount in situ hybridization to monitor expression of BMP-4 or xXBP1, respectively. We observed that BMP-4 could be ectopically activated at the dorsal side upon xXBP1 overexpression (Fig. 4B) , and vice versa, the expression of xXBP1 was also enhanced in response to BMP-4 overexpression (Fig. 4D) . We further investigated, whether xXBP1 overexpression affects the expression of Xvent-2, a BMP-4 target gene (Hata et al., 2000; Henningfeld et al., 2000) . Embryos were injected with 400 pg of xXBP1 RNA either dorsally or ventrally at the 4-cell stage, collected at stage 10.5 and subjected to whole mount in situ hybridization for Xvent-2. We found that Xvent-2 transcription was downregulated by xXBP1 overexpression in both cases (Fig. 4E-G ). These results demonstrate that BMP-4 and xXBP1 can mutually activate the transcription of each other, whereas the transcription of Xvent-2 is inhibited by xXBP1. In addition, dorsal injection of xXBP1 eradicated ADMP transcripts, and vice versa, dorsal injection of ADMP enhanced transcription of xXBP1 as compared to control (Fig. 4I-K) . This regulation between xXBP1 and ADMP explains the rescuing effect of ADMP on xXBP1 knockdown phenotype.
We also examined these regulatory relationships by RT-PCR. It was found that xXBP1 RNA injections at low doses (100 and 400 pg) led to an upregulation of the BMP-4 gene, whereas at a high dose (800 pg) the amount of BMP-4 transcripts was not affected or even slightly reduced (Fig. 4L) . In contrast, Xvent-2 expression was consistently downregulated in response to all doses of xXBP1 RNA injections (Fig. 4L) . Therefore, it might be speculated that downregulation of BMP-4 in response to high doses of xXBP1 is due to the inhibition of Xvent-2 which serves as a mediator within the auto-regulatory loop of BMP-4 expression .
We finally examined if xXBP1 transcription would be changed upon an activation of the BMP-4 pathway. In support of the results from whole mount in situ hybridizations we observed that expression of xXBP1 was upregulated in response to ectopic expression of BMP-4 (Fig. 4M) . In summary, there exists a regulatory loop between xXBP1 and the BMP-4 signaling pathway. xXBP1 can stimulate BMP-4, but inhibits Xvent-2 transcription, and vice versa, xXBP1 transcription can be stimulated by activation of BMP-4 signaling. In addition, xXBP1 inhibits ADMP expression but xXBP1 is upregulated by ADMP.
2.5. The nuclear localization signal of xXBP1 resides within the N-terminus xXBP1 is a basic region-leucine zipper (bZIP) transcription factor. While the bZIP motif locates at the N-terminus, a transactivation domain has been demonstrated for the C-terminus of the human protein (Yoshida et al., 2001) . To investigate the function of the N-and C-terminal regions in subcellular distribution, the N-terminus containing the bZIP motif comprising aa 2-120 (xXBPDC) and the C-terminus comprising aa 121-350 (xXBPDN) were subcloned within the pCS2CMT-EosFP vector, containing a myc-tag (MT) attached to a green fluorescence protein (EosFP) (Wiedenmann et al., 2004) (Fig. 5A) . To determine the subcellular localization of the two parts of xXBP1 protein, we transfected the constructs for xXBP1, xXBPDC and xXBPDN into HeLa cells. The construct pCS2CMT-EosFP was transfected as a control. We could observe that MT-EosFP distributed uniformly throughout both cytoplasm and nucleus and, as expected, the wild type xXBP1 distributed only in the nucleus (Fig. 5B) . Therefore, the MT and EosFP tags do apparently not influence the localization of the fusion protein. Interestingly, we found that the N-terminal part (xXBPDC) containing the putative DNA binding domain localized exclusively in the nucleus; whereas the C-terminal part (xXBPDN) localized primarily in the cytoplasm (Fig. 5B) . Thereby we conclude that the N-terminus of xXBP1 contains the nuclear localization signal (NLS). This notion is consistent with the prediction of a bipartite NLS within the conserved bZIP motif found in XBP1 proteins of different species (PSORT, Ensembl).
Overexpression of N-terminus and C-terminus cause phenotypic alterations
The truncated mutants (Fig. 6A) were then separately overexpressed in Xenopus embryos. When MT-xXBPDC RNA was injected at doses higher than 150 pg, all embryos died during gastrulation. When the injected dose was decreased to 100 pg, the embryos could survive till neurulation (data not shown). When the injected dose was lowered to 50 pg, the embryos survived quite well till hatching tadpole stage. However, 37 out of 40 embryos revealed significant phenotypic alterations like reduced head structures, shortening of anteriorposterior body axis and failure of neural tube closure (Fig. 6B) . This spina bifida phenotype had already been observed after injection of a C-terminal truncation lacking the myc tag (Zhao et al., 2003) . Even at a dose of 30 pg, when the body axis appeared normal, the embryos suffered from microcephaly and reduced eye size (35/44 embryos affected) as compared to uninjected controls (Fig. 6D, E) . We next injected the construct containing the C-terminus (MT-xXBPDN) and a construct which contained an artificial nuclear localization signal (NLS-MT-xXBPDN). While injections of 500 pg or 1 ng of either MT-xXBPDN or NLS-MT-xXBPDN did not result in significant alterations (data not shown), the embryos showed severely exaggerated trunk structure and a complete loss of any head structures (32/32 embryos affected (Fig. 6F) , when the injected dose for MT-xXBPDN was increased to 2.5 ng. A similar but less severe phenotype was observed for embryos injected with 2.5 ng of NLS-MT-xXBPDN (51/51 embryos affected, Fig. 6G ) which might suggest that xXBPDN exerts its function within the cytoplasm. However, it is important to note that neither the N-terminal nor the C-terminal deletion mutants can account for the phenotype, which is obtained by overexpression of the full size xXBP1 protein. This conclusion is further supported by the results of a more detailed RT-PCR analysis of mesodermal, endodermal and ectodermal marker genes (see Supplementary Fig. S2 ) and it is consistent with previous findings that the DNA binding domain is located within the N-terminus, while the transactivation domain resides within the C-terminus (Yoshida et al., 2001; Zhao et al., 2003) .
xXBP1 and its truncated mutants physically interact with BMP-responsive and TGF-b-responsive Smads, c-Jun and transcriptional co-activator p300
GST-pulldown assays were performed with GST-tagged xXBP1 and 35 S-labeled Smad1, Smad3, Smad4, Smad6, Smad7, c-Jun, p300 and p300DC. Smad1 and Smad3 are pathway-specific signal transducers for BMP-4 signaling and TGF-b signaling, respectively. The common mediator, Smad4 is used for both pathways by oligomerizing with activated pathway-specific Smads. On the other hand, Smad6 and Smad7 exert inhibitory effects on BMP-4 and TGF-b signaling pathways. Another role for Smad6 and Smad7 is that they can serve as a co-repressors (Bai et al., 2000; Lin et al., 2003) . We thought it possible that xXBP1 may interact with one or more of the Smads, because it regulates BMP-4 dependent genes. Unexpectedly, GST-pulldown assay demonstrated that xXBP1 could bind to any one of the Smads above (Fig. 7A) . Subsequent assays confirmed that the N-terminal region of xXBP1 binds to the two inhibitory Smads, Smad6 and Smad7, while the C-terminal region binds to Smad1, 3, 4, 6 and 7 (Fig. 7B) . Since xXBP1 can activate BMP-4 transcription, we asked if xXBP1 could interact with the transcriptional coactivator p300. Indeed, we found that xXBP1 did bind to p300 in pulldown assay, and the binding occurred between C-terminal region of xXBP1 (xXBPDN) and the N-terminal region of p300 (p300DC) (Fig. 7C) . Moreover, xXBP1 was also shown to interact with c-Jun (Fig. 7C) , another regulator of BMP-4 transcription . In summary, these results suggest that xXBP1 can regulate BMP-4 and, probably, also other TGF-b signaling pathways via binding to the Smad signal transducers and to distinct co-activators.
xXBP interacts with BMP-4 and Xvent-2B promoters in vitro and in vivo
It was shown that xXBP1 can regulate the transcription of BMP-4 and Xvent-2 genes in opposite direction. Moreover, xXBP1 can interact with some regulatory components, such as Smads and c-Jun, for Xvent-2 and BMP-4 transcription. We therefore asked whether or not xXBP1 interacts with the promoters of BMP-4 and Xvent-2B genes. The binding site for human XBP1 (hXBP1) has been loosely characterized as a CRE-like sequence containing an ACGT core (Clauss et al., 1996) . Such a core sequence is present in multiple copies both within the BMP-4 as well as in the Xvent-2 promoters. Electrophoretic mobility shift assays (EMSA) demonstrated that the proximal upstream regions of both the BMP-4 and Xvent-2B genes were able to bind the DNA binding region of xXBP1 in vitro (Fig. 8A) . We then used chromatin immunoprecipitation (ChIP) to detect protein-DNA interaction in vivo. Embryos were injected with mRNA for myc-tagged xXBP1 (MT-xXBP), collected at stage 11 and subsequently subjected to ChIP using anti-myc antibodies. Using primers derived from proximal BMP-4 and Xvent-2B promoters, the presence of the corresponding promoter fragments of BMP-4 and Xvent-2B genes can be detected by PCR from immunoprecipitated DNA (Fig. 8B) . To exclude the possibility of unspecific immunoprecipitation by anti-myc antibodies or DNA binding by the myc-tag, we performed ChIP in parallel with uninjected embryos and embryos injected with the myctag fused to a nuclear localization signal (NLS-MT). In both cases, no discernible products were amplified (Fig. 8B) , showing that xXBP1 interacts specifically with BMP-4 and Xvent-2B promoters in vivo in this assay.
Discussion
We here report a novel mechanism that can generate an active version of XBP1 in Xenopus embryos. During gastrulation and early neurulation, active XBP1 is produced by a conventional splice process, which leads to an elimination of exon 4. This process should be located within the nucleus. Removal of 26 nucleotides by the endoplasmic IRE1 endoribonuclease activity occurs apparently during oogenesis, but is zygotically activated only at advanced neurula stages. Whether the need for an alternative mechanism results from a lack of IRE1 during gastrulation or reflects a more rapid demand for active XBP1 during germ layer formation is under current investigation.
xXBP1 gain of function inhibits mesodermal gene expression
Overexpression of xXBP1 resulted in a phenotype which morphologically resembled that caused by activating BMP-4 signaling, i.e. ventralization of embryos (Zhao et al., 2003) . This observation suggested that xXBP1 is a regulator or a target of BMP-4 signaling. Therefore, we have investigated the regulatory circuits between xXBP1 and BMP-4 by RNA injections and subsequent whole mount in situ hybridizations. The overexpression of xXBP1 in Xenopus embryos leads to an activation of BMP-4 transcription. When we overexpressed BMP-4, we observed an enhanced transcription of xXBP1. Since Xvent-2 is a direct target gene of BMP-4 signaling (Hata et al, 2000; Henningfeld et al, 2000) , we expected that overexpression of xXBP1 should also upregulate expression of the Xvent-2 gene. But contrary to our expectation, Xvent-2 is downregulated. Therefore, xXBP1 and BMP-4 can upregulate each other, but xXBP1 inhibits transcription of the BMP-4 target gene, Xvent-2. This regulatory relationship was further confirmed by RT-PCR analysis. One disparity is that BMP-4 is activated only at a moderate dose of xXBP1 overexpression, but is not affected at higher doses. This discrepancy may be explained by the mediator function of Xvent-2 in the Fig. 7 . Physical interactions between xXBP1 deletion mutants and Smads, c-Jun, p300 and p300DC. Smads, c-Jun, p300 or p300DC were labeled with ( 35 S) methionine by in vitro translation and incubated with GST or GST tagged xXBP1 (GST-xXBP1) and its deletion mutants (GST-xXBPDC, GST-xXBPDN). Protein complexes were precipitated with beads, washed and analyzed with SDS-PAGE. (A) Pulldown assay revealed that xXBP1 interacts with Smad1, Smad3, Smad4, Smad6 and Smad7. (B) The N-terminal region of xXBP1 (GST-xXBPDC) binds to Smad6 and Smad7, while the C-terminal region of xXBP1 (GST-xXBPDN) interacts with all five Smads examined. (C) The C-terminal region of xXBP1 (GST-xXBPDN) binds to the N-terminal region of p300 (p300DC) and xXBP1 binds to c-Jun. upregulation of BMP-4 (Schuler-Metz et al., 2000) and the inhibition of Xvent-2 by xXBP1. The fact that xXBP1 activates BMP-4 but inhibits Xvent-2 suggests that the function of xXBP1 might differ from that of BMP-4 or from those of BMP-4 target genes, such as Xvent-2. Further, we have asked whether the phenotypes caused by overexpression of xXBP1 or BMP-4 are really identical, although they strongly resemble each other based on morphological characteristics. Therefore, the xXBP1 phenotype was dissected by using RT-PCR analysis. During gastrulation, dorsalizing genes, such as chordin and goosecoid, but also ventralizing genes, such as Xvent-2, were downregulated by xXBP1 overexpression. This finding suggests that xXBP1 does not only inhibit dorsal but also ventral mesoderm formation. That is to say, xXBP1 may suppress the formation of mesoderm in general. Consistent to this suggestion, expression of the pan-mesodermal gene Xbra is also found to be downregulated. Subsequently, we examined the xXBP1 overexpression phenotype with a few marker genes of tissue differentiation during later stages. Such kind of analyses has previously been done for other factors that can generate a ventralized phenotype, like for example PV.1 (Ault et al., 1996) and Xom (Ladher et al., 1996) . During late neurula and tailbud stages, overexpression of xXBP1 inhibited expression of NCAM, marking neural tissue differentiation, and XMyoD as well as a-actin, marking paraxial mesoderm and muscle differentiation. This is consistent with the fact that increased level of BMP-4 in embryos results in the inhibition of neuroectoderm (Wilson and Hemmati-Brivanlou, 1995) and muscle development (Onichtchouk et al., 1998) . a-globin is expressed in the ventralmost mesoderm; its expression is strongly inhibited in response to xXBP1 overexpression. This effect of xXBP1 is quite different from that of BMP-4, since the latter induces or elevates expression of a-globin. However, the function of xXBP1 for the inhibition of a-globin is reminiscent of the role of PV.1, which seemingly ventralizes embryos (Ault et al., 1996) , but prevents embryonic blood formation (Xu et al., 1999) .
xXBP1 knockdown promotes lateral and dorsal mesoderm formation
Inhibition of the function of ventralizing proteins will cause dorsalization of embryos as shown by a secondary axis (Onichtchouk et al., 1998) . In the functional knockdown assay on xXBP1, we did not observe any dorsalization. Instead, xXBP1 knockdown caused only significant shortening of anterior-posterior axis and bending of dorso-ventral axis. Further analyses of the morpholino injected embryos during gastrulation demonstrated that not only the pan-mesodermal marker Xbra and the dorsalizing genes chordin and goosecoid but also the ventralizing gene Xvent-2 were significantly upregulated. The upregulation of Xvent-2 may be responsible for the lack of dorsalization in the xXBP1 loss of function. At later stages, axial, paraxial and dorsal mesodermal markers were promoted. But the ventralmost mesoderm was similarly inhibited, as in the case of overexpression, leaving the function of xXBP1 for ventral mesoderm differentiation yet to be answered. By the present findings it can be postulated that xXBP1 knockdown promotes axial, paraxial and dorsal mesoderm formation.
Interaction of xXBP1 with co-activators and co-repressors
In BMP-4 or TGF-b signaling, receptor-specific Smads and co-Smad interact with specific transcription factors to bind and hence regulate the promoters of target genes (Shi and 4) . Addition of unlabeled unspecific competitor DNA is shown by white (lanes 5C6) and addition of unlabeled specific competitor DNA is shown by grey triangles (lanes 7C8). (B) ChIP. mRNA for MT-xXBP or NLS-MT was injected into all four blastomeres at 4-cell stage. Embryos were collected and subject to ChIP when uninjected control embryos grew to stage 11. ChIP with NLS-MT injected or uninjected embryos was performed in parallel under identical conditions as negative controls. For each ChIP experiment, presence of Xvent-2B and BMP-4 promoters were analyzed by PCR from DNA samples with anti-myc antibody precipitation (anti-myc), without antibody precipitation (no Ab), and from the cross-linked chromatin supernatant before immunoprecipitation (input). Massague, 2003; Cao et al., 2004 ). We here demonstrate that xXBP1 binds the BMP-4-responsive Smad1 and Smad4 in vitro. Therefore, it is possible that xXBP1 forms a regulatory complex with Smad1 and Smad4 to regulate BMP-4 target genes. The BMP-4 gene itself is subject to autoregulation, and c-Jun (AP-1) is reported to be a component in such an auto-regulatory loop. The BMP-4 gene and its flanking regions contain multiple responsive sites for c-Jun ). Here we demonstrate that xXBP1 is an additional component for the BMP-4 auto-regulatory loop and that it interacts with c-Jun. Moreover, this interaction suggests a direct interaction between xXBP1 and the BMP-4 promoter. Actually, in vitro and in vivo assays suggest that xXBP1 binds to the BMP-4 promoter. Such interactions have also been shown for the Xvent-2B gene, which is suppressed by xXBP1. How is it possible that xXBP1, on one hand, activates BMP-4 and, on the other hand, represses Xvent-2B? Regulatory activity of transcription factors often depends on the co-factors they bind. We have shown that xXBP1 can associate with the proteins p300, Smad6 and Smad7. The first protein is a well-known transcriptional coactivator because of its intrinsic histone acetyl transferase (HAT) activity (Goodman and Smolik, 2000; Chan and La Thangue, 2001 ). Smad6 and Smad7 are primarily known as inhibitory Smads (I-Smads) that negatively regulate BMP-4 and TGF-b signaling pathways by binding competitively to type I receptor or Smad1, especially in the case of Smad6 (Imamura et al., 1997; Hata et al., 1998) . Although these activities take place in the cytoplasm, I-Smads localize primarily in the nucleus (Itoh et al., 1998; Itoh et al., 2000; Nakayama et al., 1998a,b; Zhu et al., 1999) , suggesting additional functions of I-Smads within the nucleus. Indeed, Smad6 and 7 also serve as transcriptional co-repressors via interaction with histone deacetylases (HDACs) and CtBP (Bai et al., 2000; Bai and Cao, 2002; Lin et al., 2003) . Hence it seems possible, that xXBP1 may act as both transcriptional activator and repressor, depending on which cofactors are bound.
3.4. Both the bZip and the transregulatory domains are required for xXBP1 function xXBP1 contains an N-terminal bZIP region (Zhao et al., 2003) . For some transcription factors, the DNA-binding domain is enough to execute the function of the protein, while for most others, it is not. To learn more about functional domains within xXBP1, we have overexpressed the N-terminal region and the C-terminal region separately. Different morphological alterations occurred in injected embryos. Moreover, observed alterations were also not the same as those occurring in embryos overexpressing wild-type protein. After overexpression of the N-terminus, the embryos revealed microcephaly, disrupted eye structure and, especially, spina bifida, which is an indication for failure in correct convergent extension movements during gastrulation. This phenotype is also generated by dorsal injections of Smad7/8 but not by injection of Smad6 (Nakayama et al., 1998a (Nakayama et al., ,b, 2001 ). It has also been shown that Xnr3, a distinct TGF-b family member, is involved in morphogenetic movements (Smith et al., 1995) . This suggests that the function of N-terminal region of xXBP1 mimics that of Smad7/8, which attenuates the activities of TGF-b family members including Xnr3. The phenotype induced by overexpression of the C-terminus exhibits a very different morphology. This phenotype is characterized by obvious truncation of anterior structures and thickening of anteriorposterior axis. When the C-terminal region was fused to a nuclear localization signal and overexpressed in embryos, a similar but weaker phenotype was observed. This phenotype appears different from the BMP-4 induced phenotype by its exaggerated trunk structure. Therefore, it is unlikely that the corresponding phenotype is simply caused by activation of BMP-4 signaling. It has been proposed that Nodal-related proteins of the TGF-b family are responsible for anteriorposterior patterning and anterior-posterior axis positioning (Schier and Shen, 1999) . Attenuation of Nodal signaling by the inhibitors Cerberus, antivin and lefty is essential for anterior mesendoderm formation and causes anterior truncations (Meno et al., 1999; Piccolo et al., 1999; Thisse and Thisse, 1999; Thisse et al., 2000) . Overexpression of a dominant negative Xnr2 mutant at low doses resulted in only truncation of anterior structure but posterior structure remained nearly intact. When overexpressed at very high doses, both anterior and posterior structures were affected (Osada and Wright, 1999) . Similarly in zebrafish, the anterior truncated embryos still retain some axial patterns and several tail somites (Whitman, 2001 ). Hence we propose that the C-terminal region of xXBP1 might also antagonize Nodal signaling or in broader sense, TGF-b signaling. The reason is perhaps due to the binding of the C-terminal region to Smad1, 3 and 4. In transfected cells, the C-terminal region localizes in cytoplasm. Formation of a complex between these Smads and the C-terminus might prevent these Smads from entering nuclei. As a result, the BMP-4 or TGF-b target genes are not appropriately regulated. Further support for this proposal is the observation that transcription of both BMP-4 and Xvent-2 is significantly inhibited during gastrulation in embryos overexpressing the C-terminus of xXBP1 (data not shown). In contrast, the N-terminal region localizes exclusively in the nuclei. This finding suggests that the N-terminal region contains not only the DNA binding domain but also the nuclear localization signal. Noteworthy, this region binds only the two I-Smads, whereas the C-terminal region binds in addition to Smad1, Smad3, Smad4 and p300. Therefore, both the N-terminal or C-terminal regions may be responsible for binding of co-repressors, while binding of co-activators resides within the C-terminal region. Such binding should be a pre-requisite in the formation of activatory complexes that regulate xXBP1 target genes. While the DNA binding domain resides in the N-terminus, the lack of the C-terminal region prevents specific interactions with co-activators or co-repressors. Therefore, both the N-and C-terminal regions of the xXBP1 protein are required for its full biological function.
Experimental procedures
Constructs
The coding region of xXBP1 was fused in-frame to the myc-tag (MT) in pCS2CMT vector to obtain the pCS2CMT-xXBP1 construct for use in chromatin immunoprecipitation (ChIP). For an analysis of truncated mutants of xXBP1, the N-terminal region (aa 2-120) and C-terminal region (aa 121-350) were fused separately in-frame to myc-tag in pCS2CMT vector, designated as pCS2CMT-xXBPDC and pCS2CMT-xXBPDN, respectively. The C-terminal region (aa 121-350) was also fused in-frame to a nuclear localization signal (NLS) and the myc-tag in the pCS2CNLS-MT vector to get pCS2CNLS-MTxXBPDN. For GST-pulldown assays, the open reading frame of xXBP1, the N-terminal region and the C-terminal region were subcloned in pGEX-4T1 vector (Amersham) to yield GST-xXBP1, GST-xXBPDC and GST-xXBPDN, respectively. The corresponding fragments were also fused in frame to pCS2C MT-EosFP vector, which contains a coding region for green fluorescence protein (Wiedenmann et al., 2004) . The plasmids were designated as pCS2CMT-xXBP-EosFP, pCS2CMT-xXBPDC-EosFP and pCS2CMT-xXBPDN-EosFP, respectively, and used for detection of subcellular localization of proteins.
mRNA synthesis
pCS2CxXBP1, pCS2CADMP, pCS2CMT-xXBP1, pCS2CNLS-MT, pCS2CMT-xXBPDC, pCS2CMT-xXBPDN, pCS2CNLS-MT-xXBPDN, pCS2CMT-EosFP, pCS2CMT-xXBP-EosFP, pCS2CMT-xXBPDC-EosFP and pCS2CMT-xXBPDN-EosFP were linearized with NotI. pSP64T-BMP-4 was linearized with SalI. Capped mRNAs were synthesized with SP6 mMessage mMachine TM kit (Ambion).
Microinjection
Four hundred picograms of BMP-4 RNA was injected dorsally, and 400 pg of xXBP1 RNA was injected either dorsally or ventrally at the 4-cell stage, and embryos were collected at stage 10.5 (Nieuwkoop and Faber, 1967) for whole mount in situ hybridization. xXBP1 RNA was also injected at 100, 400 and 800 pg for the analysis of BMP-4 and Xvent-2 gene expression, and BMP-4 RNA was injected at 500 pg for the analysis of xXBP1 expression by RT-PCR. For marker gene analysis, 600 pg xXBP1 mRNA were injected. MT-xXBPDC RNA was injected into all four blastomeres at 4-cell stage at 30, 50, 100, 150 and 200 pg per embryo. MT-xXBPDN and NLS-MT-xXBPDN RNA were injected into all four blastomeres at 4-cell stage at 500 pg, 1.5, 2 and 2.5 ng. In the loss-of-function analysis, 50 ng of antisense morpholino oligonucleotide against xXBP1 RNA containing the sequence 5 0 -GCTCCCACGACCAC-CATGTTGAAGG-3 0 (MOxXBP) or a standard control morpholino oligo (ctrlMO) (GeneTools) was injected into all blastomeres at 4-cell stage. To rescue the developmental defect caused by MOxXBP, the morpholino was coinjected with either 200 pg of xXBP1, 50 pg of BMP-4 or 40 pg of ADMP RNAs. Injected embryos were cultured to desired stages according to Nieuwkoop and Faber (1967) and collected either for scoring the phenotype or for RT-PCR.
RT-PCR
Total RNA was extracted from embryos, digested by DNase I and purified using RNeasy kit (Qiagen). First strand cDNA was synthesized with RevertAid TM H Minus first strand cDNA synthesis kit (Fermentas). Expression of marker genes was examined by PCR using the following primers:
ODC ( 
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed according to a protocol described elsewhere (Harland, 1991) .
In vitro assay of antisense morpholino oligo on protein translation
In vitro protein translation was performed with TNT Coupled Reticulocyte Lysate Systems (Promega). 1 mg of pBK-CMV-xXBP1 plasmid containing the 5 0 -UTR and 3 0 -UTR (Zhao et al., 2003) was used either alone or together with 25 mg MOxXBP or 25 mg ctrlMO for in vitro translation. Translation products were subjected to SDS-PAGE and autoradiography.
Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP)
Hexa-His-tagged xXBP1 (amino acids 1-153 containing the DNA binding domain) was expressed in Escherichia coli BL21 (DE3) (Stratagene) and purified under native conditions using Ni-NTA-agarose (Qiagen) according to the manufacturer's protocol. The purified proteins were quantified by the Bradford method. DNA fragments were amplified by PCR using 5 0 -labeled primers. Binding reactions were carried out on ice for 30 min in 30 ml binding buffer (25 mM Tris (pH 8.0), 50 mM KCL, 6.25 mM MgCl 2 , 0.5 mM EDTA, 10% glycerol, 0.5 mM DTT, 0.25 mg poly (dI-dC) and 1 ng of the gel-purified probe. Samples were then subjected to polyacrylamide gel electrophoresis. For ChIP analysis, 500 pg MT-xXBP1 RNA were injected into four blastomeres at 4-cell stage and ChIP was performed on embryos collected at stage 11. To exclude the possibility that the myc-tag binds to the Xvent-2B or BMP-4 promoter region, 500 pg RNA for myc-tag fused to nuclear localization signal at C-terminus (NLS-MT) was also injected for a negative control. ChIP was performed as described (Cao et al., 2004) under identical conditions for all experiments. 30 cycles of PCR were carried out.
Primers were used as follows: Xvent-2B: forward 5 0 -TGAGCATCACA- 
GST-pulldown assay
GST pull-down assays were performed as described . Glutathione S-transferase (GST)-tagged proteins were isolated using glutathione-Sepharose according to the manufacturer's protocols (Amersham Biosciences).
35
S-labeled proteins Smad1, Smad3, Smad4, Smad6, Smad7, c-Jun, p300 and p300 lacking the C-terminal region p300DC (Oswald et al., 2001) were prepared using the TNT-coupled transcription-translation system (Promega).
Cell transfection
HeLa cells (ATCC CCL 2) were grown at 37 8C under 5% CO 2 in Dulbecco's Modified Eagle Medium (DMEM, Gibco) supplemented with 10% fetal calf serum (FCS). Transfection with the indicated expression plasmids was performed using Fugene transfection reagent (Roche). Subcellular localization of proteins was analyzed 24 h after transfection using fluorescence microscope (DMIRB, Leica).
